
Prelude Therapeutics Incorporated
PRLDHealthcare|Biotechnology|US
$3.60
+0.04 (+1.27%)
DCF Value
$3.79
Tangible Book / Share
$1.36
Cash / Share
$1.54
Ownership Breakdown
56.0%
Float
79.8M
Shares Outstanding
44.7M
Float Shares
Major Holders (23)
Combined: 188.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | Investment adviser | 16.00% | 12,935,071 | Apr 23, 2026 | 13D/G |
| Baker Bros. Advisors (GP) LLC | HC, OO | 15.50% | 10,295,301 | Apr 22, 2026 | 13D/G |
| Felix J. Baker | HC, IN | 15.50% | 10,295,301 | Apr 22, 2026 | 13D/G |
| Julian C. Baker | HC, IN | 15.50% | 10,295,301 | Apr 22, 2026 | 13D/G |
| Baker Bros. Advisors LP | IA, PN | 15.50% | 10,295,301 | Apr 22, 2026 | 13D/G |
| Orbimed Capital GP VI LLC | Other | 14.60% | 11,808,945 | Apr 23, 2026 | 13D/G |
| Vaddi Krishna | Individual | 13.15% | 6,745,647 | Feb 13, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 6,477,309 | Apr 28, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.90% | 6,477,309 | Apr 28, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 6,477,309 | Apr 28, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 6,477,309 | Apr 28, 2026 | 13D/G |
| Incyte Corp | Corporation | 9.90% | 4,372,124 | Nov 7, 2025 | 13D/G |
| Levy Guy | Individual | 5.20% | 3,378,378 | Jul 8, 2026 | 13D/G |
| Soleus GP, LLC | Other | 5.20% | 3,378,378 | Jul 8, 2026 | 13D/G |
| Soleus Capital Management, L.P. | Partnership | 5.20% | 3,378,378 | Jul 8, 2026 | 13D/G |
| Soleus Capital Group, LLC | Other | 4.20% | 2,702,702 | Jul 8, 2026 | 13D/G |
| Soleus Capital, LLC | Other | 4.20% | 2,702,702 | Jul 8, 2026 | 13D/G |
| Soleus Capital Master Fund, L.P. | Non-US institution | 4.20% | 2,702,702 | Jul 8, 2026 | 13D/G |
| OrbiMed Genesis GP LLC | Other | 1.40% | 1,126,126 | Apr 23, 2026 | 13D/G |
| Soleus Private Equity Fund III, L.P. | Partnership | 1.00% | 675,676 | Jul 8, 2026 | 13D/G |
| Soleus Private Equity GP III, LLC | Other | 1.00% | 675,676 | Jul 8, 2026 | 13D/G |
| Soleus PE GP III, LLC | Other | 1.00% | 675,676 | Jul 8, 2026 | 13D/G |
| Orbimed Capital LLC | Investment adviser | 1.00% | 789,500 | Apr 23, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 11,679,917 acquired · 1,432,460 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Jun 9, 2026 | AWARD | 38,000 | $3.94 | $149.7K | Form 4 |
| Dorton Katina | director | Jun 9, 2026 | AWARD | 38,000 | $3.94 | $149.7K | Form 4 |
| Babler Martin | director | Jun 9, 2026 | AWARD | 38,000 | $3.94 | $149.7K | Form 4 |
| Bonita David P | director, 10 percent owner: | Jun 9, 2026 | AWARD | 38,000 | $3.94 | $149.7K | Form 4 |
| Sandor Victor | director | Jun 9, 2026 | AWARD | 38,000 | $3.94 | $149.7K | Form 4 |
| FRIEDMAN PAUL A | director | Jun 9, 2026 | AWARD | 38,000 | $3.94 | $149.7K | Form 4 |
| Morris Charles Q | Chief Medical Officer | May 1, 2026 | AWARD | 450,000 | $4.70 | $2.1M | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Apr 27, 2026 | DISPOSED | 1,407,000 | $0.00 | $140.70 | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Apr 27, 2026 | J | 1,407,000 | $0.00 | $140.70 | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Apr 21, 2026 | OTHER | 0 | — | — | Form 4 |
| Bonita David P | director, 10 percent owner: | Apr 21, 2026 | BUY | 1,689,189 | $4.44 | $7.5M | Form 4 |
| Bonita David P | director, 10 percent owner: | Apr 21, 2026 | BUY | 1,126,126 | $4.44 | $5.0M | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Apr 21, 2026 | BUY | 1,689,189 | $4.44 | $7.5M | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Apr 21, 2026 | BUY | 1,126,126 | $4.44 | $5.0M | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Apr 21, 2026 | BUY | 2,137,651 | $0.00 | $213.77 | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Apr 21, 2026 | BUY | 114,601 | $0.00 | $11.46 | Form 4 |
| Morris Charles Q | Apr 15, 2026 | OTHER | 0 | — | — | Form 4 | |
| Brusky Sean P. | Chief Business Officer | Mar 5, 2026 | OTHER | 0 | — | — | Form 4 |
| Brusky Sean P. | Chief Business Officer | Mar 5, 2026 | OTHER | 275,000 | — | — | Form 4 |
| Combs Andrew | Chief Chemistry Officer | Feb 4, 2026 | AWARD | 230,000 | $2.30 | $529.0K | Form 4 |
| Scherle Peggy | Chief Scientific Officer | Feb 4, 2026 | AWARD | 230,000 | $2.30 | $529.0K | Form 4 |
| Lim Bryant David | CLO, CFO, Corp Sec. | Feb 4, 2026 | AWARD | 275,000 | $2.30 | $632.5K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Feb 4, 2026 | AWARD | 837,000 | $2.30 | $1.9M | Form 4 |
| Sandor Victor | director | Nov 5, 2025 | AWARD | 121,285 | $1.39 | $168.6K | Form 4 |
| Dorton Katina | Oct 17, 2025 | OTHER | 0 | — | — | Form 4 | |
| Huang Jane | President, CMO | Oct 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Oct 4, 2025 | TAX W/H | 3,355 | $1.47 | $4.9K | Form 4 |
| Huang Jane | President, CMO | Oct 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2025 | TAX W/H | 3,355 | $0.79 | $2.7K | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Jun 12, 2025 | AWARD | 76,000 | $1.04 | $79.0K | Form 4 |
| Scherer Paul C | Jun 12, 2025 | OTHER | 0 | — | — | Form 4 | |
| Sandor Victor | director | Jun 12, 2025 | AWARD | 38,000 | $1.04 | $39.5K | Form 4 |
| Dier Mardi | director | Jun 12, 2025 | AWARD | 38,000 | $1.04 | $39.5K | Form 4 |
| FRIEDMAN PAUL A | director | Jun 12, 2025 | AWARD | 38,000 | $1.04 | $39.5K | Form 4 |
| Bonita David P | director, 10 percent owner: | Jun 12, 2025 | AWARD | 38,000 | $1.04 | $39.5K | Form 4 |
| Babler Martin | director | Jun 12, 2025 | AWARD | 38,000 | $1.04 | $39.5K | Form 4 |
| Huang Jane | President, CMO | Apr 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Apr 4, 2025 | TAX W/H | 3,355 | $0.68 | $2.3K | Form 4 |
| Huang Jane | President, CMO | Apr 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Combs Andrew | Chief Chemistry Officer | Mar 25, 2025 | BUY | 100,000 | $0.69 | $69.3K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 25, 2025 | BUY | 675,000 | $0.69 | $467.4K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 21, 2025 | BUY | 15,000 | $0.73 | $11.0K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 20, 2025 | BUY | 5,416 | $0.73 | $4.0K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 17, 2025 | BUY | 9,106 | $0.75 | $6.8K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 14, 2025 | BUY | 29,999 | $0.75 | $22.6K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 13, 2025 | BUY | 50,000 | $0.72 | $35.8K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 12, 2025 | BUY | 47,500 | $0.71 | $33.7K | Form 4 |
| Lim Bryant David | CLO, CFO, Corp Sec. | Feb 4, 2025 | AWARD | 200,000 | $1.11 | $222.0K | Form 4 |
| Scherle Peggy | Chief Scientific Officer | Feb 4, 2025 | AWARD | 175,000 | $1.11 | $194.3K | Form 4 |
| Combs Andrew | Chief Chemistry Officer | Feb 4, 2025 | AWARD | 175,000 | $1.11 | $194.3K | Form 4 |
| Huang Jane | President, CMO | Feb 4, 2025 | AWARD | 200,000 | $1.11 | $222.0K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Feb 4, 2025 | AWARD | 496,000 | $1.11 | $550.6K | Form 4 |
| Huang Jane | President, CMO | Jan 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jan 4, 2025 | TAX W/H | 3,859 | $1.39 | $5.4K | Form 4 |
| Huang Jane | President, CMO | Jan 4, 2025 | OPTION EX. | 9,375 | — | — | Form 4 |
| Vaddi Krishna | director, officer: CEO | Dec 31, 2024 | BUY | 5,000 | $1.21 | $6.0K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Dec 30, 2024 | BUY | 10,000 | $1.20 | $12.0K | Form 4 |
| Combs Andrew | Chief Chemistry Officer | Dec 23, 2024 | BUY | 60,000 | $1.37 | $82.0K | Form 4 |
| Combs Andrew | Chief Chemistry Officer | Dec 20, 2024 | BUY | 3,075 | $1.15 | $3.5K | Form 4 |
| Lim Bryant David | CLO, Interim CFO, Corp Sec. | Dec 19, 2024 | BUY | 25,000 | $0.91 | $22.6K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Dec 18, 2024 | BUY | 100,000 | $0.93 | $93.2K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Dec 19, 2024 | BUY | 6,888 | $0.89 | $6.1K | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2024 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2024 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2024 | TAX W/H | 3,347 | $3.60 | $12.0K | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Jun 14, 2024 | AWARD | 23,500 | $3.90 | $91.7K | Form 4 |
| Sandor Victor | director | Jun 14, 2024 | AWARD | 23,500 | $3.90 | $91.7K | Form 4 |
| FRIEDMAN PAUL A | director | Jun 14, 2024 | AWARD | 23,500 | $3.90 | $91.7K | Form 4 |
| Dier Mardi | director | Jun 14, 2024 | AWARD | 23,500 | $3.90 | $91.7K | Form 4 |
| Bonita David P | director, 10 percent owner: | Jun 14, 2024 | AWARD | 23,500 | $3.90 | $91.7K | Form 4 |
| Babler Martin | director | Jun 14, 2024 | AWARD | 23,500 | $3.90 | $91.7K | Form 4 |
| Lim Bryant David | CLO, Interim CFO, Corp Sec. | May 14, 2024 | AWARD | 25,000 | $3.86 | $96.5K | Form 4 |
| Huang Jane | President, CMO | Apr 4, 2024 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Apr 4, 2024 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Apr 4, 2024 | TAX W/H | 3,347 | $4.74 | $15.9K | Form 4 |
| Lim Bryant David | Chief Legal Officer, Corp Sec. | Mar 1, 2024 | AWARD | 150,000 | $4.59 | $688.5K | Form 4 |
| Scherle Peggy | Chief Scientific Officer | Mar 1, 2024 | AWARD | 150,000 | $4.59 | $688.5K | Form 4 |
| Combs Andrew | Chief Chemistry Officer | Mar 1, 2024 | AWARD | 150,000 | $4.59 | $688.5K | Form 4 |
| Chardonnet Laurent | Chief Financial Officer | Mar 1, 2024 | AWARD | 150,000 | $4.59 | $688.5K | Form 4 |
| Huang Jane | President, CMO | Mar 1, 2024 | AWARD | 175,000 | $4.59 | $803.3K | Form 4 |
| Vaddi Krishna | director, officer: CEO | Mar 1, 2024 | AWARD | 425,000 | $4.59 | $2.0M | Form 4 |
| Huang Jane | President, CMO | Jan 4, 2024 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jan 4, 2024 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jan 4, 2024 | TAX W/H | 3,844 | $3.77 | $14.5K | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Dec 13, 2023 | AWARD | 7,343,307 | $0.00 | $734.33 | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Dec 13, 2023 | AWARD | 593,452 | $0.00 | $59.35 | Form 4 |
| Huang Jane | President, CMO | Oct 4, 2023 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Oct 4, 2023 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2023 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2023 | OPTION EX. | 9,375 | — | — | Form 4 |
| Huang Jane | President, CMO | Jul 4, 2023 | TAX W/H | 3,242 | $4.65 | $15.1K | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Jun 16, 2023 | AWARD | 23,500 | $5.56 | $130.7K | Form 4 |
| Sandor Victor | director | Jun 16, 2023 | AWARD | 23,500 | $5.56 | $130.7K | Form 4 |
| FRIEDMAN PAUL A | director | Jun 16, 2023 | AWARD | 23,500 | $5.56 | $130.7K | Form 4 |
| Dier Mardi | director | Jun 16, 2023 | AWARD | 23,500 | $5.56 | $130.7K | Form 4 |
| Bonita David P | director, 10 percent owner: | Jun 16, 2023 | AWARD | 23,500 | $5.56 | $130.7K | Form 4 |
| Babler Martin | director | Jun 16, 2023 | AWARD | 23,500 | $5.56 | $130.7K | Form 4 |
| Vaddi Krishna | director, officer: CEO | May 25, 2023 | BUY | 900 | $5.31 | $4.8K | Form 4 |